Immunocore

NASDAQ: IMCR · Real-Time Price · USD
32.94
-0.12 (-0.36%)
At close: Aug 15, 2025, 3:59 PM
32.88
-0.17%
After-hours: Aug 15, 2025, 04:10 PM EDT

Immunocore Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
97.96M 93.88M 84.05M 80.25M 75.4M 70.5M 105.64M 62.62M 60.48M 55.06M 48.06M 41.2M 32M 22.47M 6.59M 5.92M 5.73M 8.27M
Cost of Revenue
1.04M 831K 330K 448K 1.71M 246K -247K 267.59K 1.12M 220.02K 109K 63K 34K 248K n/a n/a n/a n/a
Gross Profit
96.92M 93.05M 83.72M 79.8M 73.69M 70.26M 105.88M 62.36M 59.36M 54.84M 47.95M 41.14M 31.97M 22.23M 6.59M 5.92M 5.73M 8.27M
Operating Income
-14.88M -3.62M -19.45M -8.5M -16.02M -26.49M -25.79M -850.19K -19.97M -21.49M -22.33M -9.01M -13.77M -16.46M -37.83M -30.95M -34.5M -31.88M
Interest Income
4.27M 4.18M 5.13M 6.02M 6.25M 8.25M 7.94M 5.14M 4.28M 3.13M 2.43M 597K 118K 10K 7.04K 8K 12K 22K
Pretax Income
-9.69M 6.08M -24.82M 6.09M -10.13M -24.08M -32.26M 2.14M -17.63M -20.35M -23.07M 4.98M -8.27M -17.78M -39.17M -32.26M -35.77M -33.72M
Net Income
-10.3M 5.02M -23.77M 8.74M -11.62M -24.44M -26.42M 2.32M -17.83M -20.64M -25.2M 6.23M -6.12M -16.13M -39.39M -30.13M -32.96M -29.04M
Selling & General & Admin
42.79M 40.2M 42.32M 35.53M 38.64M 39.29M 57.13M 13.37M 45.6M 41.16M 43.14M 25.88M 24.51M 20.11M 24.37M 20.05M 23.8M 20.18M
Research & Development
69.01M 56.47M 60.85M 52.77M 51.07M 57.46M 74.65M 38.53M 36.43M 35.16M 27.14M 23.3M 20.15M 18.58M 20.07M 16.8M 16.47M 19.89M
Other Expenses
n/a n/a n/a n/a n/a -190K n/a n/a n/a -401.72K -2K 964K 1.08M -1K -85K 28K -40K 82K
Operating Expenses
111.8M 96.67M 103.17M 88.3M 89.71M 96.75M 131.78M 51.9M 82.03M 76.33M 70.28M 50.15M 45.74M 38.69M 44.42M 36.87M 40.23M 40.15M
Interest Expense
-3.04M 3.02M 6.97M 4.33M 4.28M 3.24M 337K 1.32M 1.27M 1.25M 3.18M 1.78M 1.4M 1.33M 1.85M 1.32M 1.29M 1.86M
Selling & Marketing Expenses
n/a n/a -24.67M 11.62M 13.05M n/a 17.2M n/a n/a n/a n/a 7.47M 8.19M n/a n/a n/a n/a n/a
Cost & Expenses
112.84M 97.5M 103.5M 88.75M 91.42M 96.99M 131.53M 52.17M 83.15M 76.55M 70.39M 50.21M 45.77M 38.93M 44.42M 36.87M 40.23M 40.15M
Income Tax Expense
-606K -1.06M -1.04M -2.64M 1.49M 357K -5.85M -175.15K 191.22K 291.71K 2.13M -1.24M -2.15M -1.66M 214K -2.13M -2.81M -4.68M
Shares Outstanding (Basic)
50.29M 50.09M 49.99M 50.02M 50.01M 49.88M 48.89M 54.16M 48.69M 48.18M 46.67M 51.44M 43.94M 43.87M 43.67M 43.67M 43.79M 38.45M
Shares Outstanding (Diluted)
50.29M 51.95M 49.99M 52.81M 50.01M 49.88M 48.89M 54.16M 48.69M 48.18M 46.67M 51.44M 43.94M 43.87M 43.86M 43.8M 43.79M 38.45M
EPS (Basic)
-0.2 0.10 -0.47 0.17 -0.23 -0.49 -0.54 0.05 -0.37 -0.43 -0.54 0.13 -0.14 -0.37 -0.9 -0.69 -0.75 -0.76
EPS (Diluted)
-0.2 0.10 -0.47 0.17 -0.23 -0.49 -0.54 0.05 -0.37 -0.43 -0.54 0.12 -0.14 -0.37 -0.9 -0.69 -0.75 -0.76
EBITDA
-14.88M 9.96M -16.46M 10.91M -16.02M -20.19M -18.74M 3.13M -14.46M -16.95M -25.25M 8.25M -5.36M -14.77M -37.83M -29.24M -32.71M -30.05M
EBIT
n/a 9.11M -16.44M 9.87M -6.37M -20.84M -26.69M 2.05M -15.55M -17.91M -27.31M 6.77M -6.88M -16.45M -51.73M -30.94M -34.49M -31.86M
Depreciation & Amortization
n/a 854K -22.92K 1.03M 992K 1.01M 121K 1.66M 2.09M 1.18M 1.34M 1.48M 1.64M 1.68M 1.72M 1.71M 1.77M 1.81M